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Animal studies have linked perinatal bisphenol A
(BPA) exposure to altered DNA methylation, but
little attention is given to analyzing multiple physi-
ologically relevant doses. Utilizing the viable yel-
low agouti (Avy) mouse, we examine the effects of
developmental exposure through maternal diet to
50 ng BPA/kg (n 5 14 litters), 50 lg BPA/kg (n
5 9 litters), or 50 mg BPA/kg (n 5 13 litters) on
global and candidate gene methylation at post-
natal day 22. Global methylation analysis reveals
hypermethylation in tail tissue of a/a and Avy/a
offspring across all dose groups compared with
controls (n 5 11 litters; P < 0.02). Analysis of
coat color phenotype replicates previous work
showing that the distribution of 50 mg BPA/kg
Avy/a offspring shifts toward yellow (P 5 0.006)
by decreasing DNA methylation in the retrotrans-
poson upstream of the Agouti gene (P 5 0.03).
Maternal exposure to 50 lg or 50 ng BPA/kg,
however, results in altered coat color distributions
in comparison with control (P 5 0.04 and 0.02),
but no DNA methylation effects at the Agouti
gene are noted. DNA methylation at the CDK5
activator-binding protein (CabpIAP) metastable epi-
allele shows hypermethylation in the 50 lg BPA/
kg offspring, compared with controls (P 5 0.02).
Comparison of exposed mouse liver BPA levels to
human fetal liver BPA levels indicates that the
three experimental exposures are physiologically
relevant. Thus, perinatal BPA exposure affects off-
spring phenotype and epigenetic regulation
across multiple doses, indicating the need to eval-
uate dose effects in human clinical and population
studies. Environ. Mol. Mutagen. 53:334–342,
2012. VC 2012 Wiley Periodicals, Inc.
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INTRODUCTION
A growing body of work supports the developmental
origins of health and disease hypothesis, in which chemi-
cal and nutritional exposures early in development influ-
ence chronic disease outcomes in adulthood [Barker,
2004; Bateson et al., 2004]. Epigenetic modifications,
such as DNA methylation and histone modifications,
established early in development can shape susceptibility
to disease, resulting in diverse phenotypes among geneti-
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cally identical individuals [Rakyan et al., 2002]. For
example, metastable epialleles are genes that are variably
expressed due to epigenetic modifications established
early in development, thus making them vulnerable tar-
gets to environmental disruption during gestation [Rakyan
et al., 2002; Waterland and Jirtle, 2004]. A handful of
murine metastable epialleles have been identified (Avy,
AxinFu, CabpIAP) in which the activity of a contraoriented
intracisternal A particle (IAP) retrotransposon controls
expression of an adjacent gene (Fig. 1) [Duhl et al., 1994;
Vasicek et al., 1997; Ruvinsky et al., 2001; Rakyan et al.,
2002; Druker et al., 2004]. Importantly, DNA methylation
patterns at these metastable epialleles have been shifted
following maternal exposure to nutritional and environ-
mental factors, including bisphenol A (BPA) [Cooney
et al., 2002; Waterland and Jirtle, 2003; Dolinoy et al.,
2006, 2007; Kaminen-Ahola et al., 2010].
Accumulating work suggests that early BPA exposure
increases susceptibility for adverse phenotypic outcomes
via epigenetic mechanisms. BPA is a chemical used for
the industrial manufacturing of polycarbonate plastics and
epoxy resins. There are multiple routes of BPA exposure
including ingestion, dermal absorption, and inhalation due
to its widespread use in commercial products such as
food and beverage containers, baby bottles, dental seal-
ants, and receipt paper [Vandenberg et al., 2007]. Recur-
rent exposure to BPA is evident from detectable levels
present in greater than 92% of the United States popula-
tion [Calafat et al., 2008]. As an endocrine active com-
pound, BPA can exert estrogenic activity by interfering
with estrogen receptors alpha and beta, and estrogen
related receptor gamma even at low exposure levels [vom
Saal et al., 2006]. Additionally, BPA has an antagonistic
effect on thyroid hormone signaling [Moriyama et al.,
2002; Rubin et al., 2009].
Early exposure to BPA may promote chronic disease
development such as prostate and breast cancer, type 2 di-
abetes, and obesity as well as impaired brain development
and behavior by altering the developing epigenome [Jirtle
and Skinner, 2007; Kundakovic and Champagne, 2011].
For example, early developmental exposure to 10 lg
BPA/kg BW/day decreased methylation of the phosphodi-
esterase type 4 variant 4 gene in prostate cancer cells in
adult male rats [Ho et al., 2006; Prins et al., 2008]. Addi-
tionally, in utero exposure to 5 mg BPA/kg BW in CD-1
mice on days 9–16 of pregnancy decreased methylation in
the promoter region of Hoxa10, a gene involved in uterine
organogenesis [Bromer et al., 2010]. Previously, our
group reported a shift toward DNA hypomethylation at
the viable yellow agouti (Avy) and CDK5 activator-bind-
ing protein (CabpIAP) metastable epialleles (Figs. 1A and
1B) in offspring exposed to a relatively high dosage of
BPA (50 mg BPA/kg diet) perinatally [Dolinoy et al.,
2007]. Moreover, restoration of normal methylation pat-
terns occurred with maternal supplementation of genistein
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Fig. 1. Avy and CabpIAP loci (A) The Avy allele contains a contra-ori-
ented IAP insertion within pseudoexon 1A (PS1A) of the Agouti gene. A
cryptic promoter (short arrowhead labeled Avy ectopic) drives constitutive
ectopic Agouti expression. Transcription of the Agouti gene normally ini-
tiates from a developmentally regulated hair-cycle specific promoter in
exon 2 (short arrowhead labeled A, a wildtype). The location of the
bisulfite-converted genomic reverse primer for amplifying the Avy IAP is
underlined. (B) The CabpIAP metastable epiallele contains a contra-ori-
ented IAP insertion within intron 6 of the murine CDK5 activator-bind-
ing protein (Cabp) gene, resulting in short aberrant transcripts originat-
ing from the 50-LTR of the IAP (short arrowhead labeled Cabp AT1a,b).
Aberrant transcripts also originate at the normal transcription start site
(short arrowhead labeled Cabp wildtype) and truncate 50 of the IAP
insertion (Cabp AT2 and AT3). Normal Cabp transcription covers 14
exons, resulting in a 2-kb transcript. The location of the bisulfite-con-
verted genomic reverse primer for amplifying the CabpIAP locus is
underlined.
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or methyl donors such as folate, choline, betaine, and
vitamin B12 [Dolinoy et al., 2006, 2007].
Previous epigenetics studies involving BPA have not
captured the full range of human physiologically relevant
exposure levels, and most attempts to elucidate the effects
on the epigenome following environmental manipulations,
including perinatal exposure to BPA, have been restricted
in dose-response assessment. Thus, utilizing the viable yel-
low agouti (Avy) mouse model, we examined global and
candidate gene methylation patterns following perinatal ex-
posure at three dosages (50 ng, lg, and mg of BPA/kg
diet). The murine Avy allele resulted from the random
insertion of a murine IAP retrotransposon into the 50 end
of the Agouti gene (Fig. 1A) [Duhl et al., 1994]. Methyla-
tion of CpG sites in and near the Avy IAP correlates inver-
sely with ectopic Agouti expression and varies dramatically
among isogenic Avy/a mice, resulting in a wide array of
coat colors, ranging from yellow (unmethylated) to pseu-
doagouti (methylated), and additionally results in adult-
onset obesity (10 weeks of age) among low methylated
mice [Miltenberger et al., 1997; Morgan et al., 1999]. To
our knowledge, this is the first study to utilize the Avy
mouse model as an epigenetic biosensor to evaluate mater-
nal exposure to multiple, rather than single dose levels.
METHODS
Animals and Diet
Avy mice were obtained from a colony that has been maintained with
sibling mating and forced heterozygosity for the Avy allele for over 220
generations, resulting in a genetically invariant background [Waterland
and Jirtle, 2003]. Virgin a/a dams, 6 weeks of age, were randomly
assigned to one of four phytoestrogen-free AIN-93G diets (diet 95092
with 7% corn oil substituted for 7% soybean oil; Harlan Teklad, Madi-
son, WI): (1) standard diet (n 5 11 litters, 86 total offspring, 39 Avy/a
offspring); (2) standard diet supplemented with 50 ng BPA/kg diet (n 5
14 litters, 107 total offspring, 48 Avy/a offspring); (3) standard diet sup-
plemented with 50 lg BPA/kg diet (n 5 9 litters, 67 total offspring, 32
Avy/a offspring); (4) standard diet supplemented with 50 mg BPA/kg diet
(n 5 13 litters, 91 total offspring, 45 Avy/a offspring). All diet ingre-
dients were supplied by Harlan Teklad except BPA, which was supplied
by NTP (National Toxicology Program, Durham NC). The mg dosage
was formulated to be an order of magnitude lower than the dietary
administered maximum nontoxic threshold in rodents (200 mg/kg BW/
day) [Takahashi et al., 2003], whereas the ng and lg BPA dosages were
used to potentially capture the physiologically relevant range of human
exposure.
Following 2 weeks on their respective diets, at 8 weeks of age a/a vir-
gin dams were mated with Avy/a males, 7–8 weeks of age. All animals
were housed in polycarbonate-free cages and provided ad libitum access
to diet and BPA-free water. The dams remained on the assigned diets
throughout pregnancy and lactation. At postnatal day 22 (d22), a/a and
Avy/a offspring were weighed and tail-tipped. In addition, at d22, a single
observer visually classified Avy/a offspring coat color phenotype into one
of five categories based on proportion of brown fur: yellow (<5%
brown), slightly mottled (between 5 and 40% brown), mottled (50%
brown), heavily mottled (between 60 and 95% brown), and pseudoagouti
(>95% brown). Tail tissue was collected for analysis from all offspring.
Animals used in this study were maintained in accordance with the
Guidelines for the Care and Use of Laboratory Animals [Institute of
Laboratory Animal Resources, 1996] and were treated humanely and
with regard for alleviation of suffering. The study protocol was approved
by the University of Michigan Committee on Use and Care of Animals.
DNA Isolation andMethylation Analysis
Total genomic DNA was isolated from d22 tail tissue of all a/a and
Avy/a offspring using magnetic particle-based methodology and the Max-
well 161 Instrument (Promega Corporation, Madison, WI). The Lumino-
metric Methylation Assay (LUMA), a methylation-sensitive restriction
enzyme digest followed by quantitative DNA methylation analysis via
pyrosequencing, was utilized to analyze global DNA methylation at
CCGG sites throughout the mouse genome using genomic DNA [Karimi
et al., 2006]. Approximately 300 ng of genomic DNA was digested with
both HpaII, an endonuclease sensitive to CpG methylation, and MspI, an
endonuclease insensitive to CpG methylation; both endonucleases cut
CCGG sites between the first and second cytosines. EcoRI was used in
both restriction enzyme reactions as a normalization reference [Karimi
et al., 2006]. Following DNA digestion, samples were pyrosequenced in
duplicate to quantify CCGG DNA methylation. The pyrosequencing out-
put provides the incorporation of dCTP, which is directly correlated with
DNA methylation. The ratio of digested sites to undigested sites was cal-
culated and represents the percentage of genomic DNA methylation.
Duplicates with measurement differences greater than 15% were omitted
prior to statistical analysis.
Using the Qiagen Epitect kit automated on the Qiagen QIAcube1 pu-
rification system, approximately 1 lg of genomic DNA was treated with
sodium bisulfite to allow conversion of unmethylated cytosines to uracil,
read as thymine during polymerase chain reaction (PCR), whereas the
methylated cytosines remain unconverted [Grunau et al., 2001]. Follow-
ing bisulfite conversion, candidate gene regions of interest were ampli-
fied using HotStarTaq master mix (Qiagen Inc., Valencia, CA), forward
primer (0.5 pmol) and reverse primer (0.5 pmol) in a 30 lL PCR and
resolved by gel electrophoresis. PCR and sequencing primers for assays
are listed in Table I. DNA methylation of CpG sites of interest was
quantified using PyroMark MD (Qiagen Inc., Valencia, CA) pyrose-
quencing technology. Percent methylation was computed using PyroMark
software, which calculates the degree of methylation as percent 5-meth-
ylated cytosines (%5mC) over the sum of methylated and unmethylated
cytosines. All samples were run in duplicate using the average CpG site
methylation of the duplicates for statistical analysis. Sequences to ana-
lyze for pyrosequencing runs are provided in Table I. The four CpG sites
studied at the Avy allele are located at nucleotide positions 306, 319,
322, and 334 of GenBank accession number AF540972.1. The four CpG
sites studied at the CabpIAP allele are located at nucleotide positions 44,
57, 60, and 72 of GenBank accession number BB842254.
Statistical Analysis
The influence of gestational BPA exposure on litter size, survival,
wean weight, genotypic ratio and sex ratio was evaluated using ANOVA
with Bonferroni post-hoc analysis. The distribution of the five coat color
phenotypes between each exposure group was analyzed using a Chi-square
goodness-of-fit test, with the control coat color distribution representing the
expected distribution. All comparisons resulted in cell counts with no more
than 20% of cells containing fewer than five observations. The influence of
sex, genotype and coat color on mean CpG methylation was measured
using ANOVA with Bonferroni corrections. Average CpG methylation
within an amplicon, site-specific CpG methylation, and global methylation
among the three BPA exposed groups and the control group were eval-
uated by two-sample hypothesis analysis of means and ANOVA with Bon-
ferroni correction as post-hoc analyses. Statistical significance was defined
as P-value < 0.05 for all analyses. Normality of percent methylation was
Environmental and Molecular Mutagenesis. DOI 10.1002/em
336 Anderson et al.
evaluated using histograms and Q-Q plots. Outliers defined as having a stu-
dentized residual greater than 2.0 were excluded in the final methylation
analysis. The resulting exclusion of outliers consisted of 2 mg exposed sub-
jects for Avy locus methylation analysis. All statistical analyses were com-
pleted using SAS software version 9.2 (Cary, NC).
BPA Analysis in Liver
Approximately 300–500 mg of d22 Avy/a mouse liver tissue (n 5 8–
11 per exposure group) was flash frozen and homogenized to fine pow-
der over a mortar above liquid nitrogen. Homogenized tissue was trans-
ferred into a 2 mL polypropylene eppendorf tube and transported over-
night on dry ice to the Wadsworth Center (New York State Department
of Health, Albany, NY). Five mL of acetonitrile and 5 ng of 13C12-BPA,
an internal standard, were added to homogenized tissue, and the mixture
was shaken for 30 min. Extraction with acetonitrile was repeated twice
and the mixture was centrifuged at 4,500g for 3 min. Combined aliquots
were concentrated to near-dryness under a gentle stream of nitrogen and
reconstituted with 1.5 mL of 10% dichloromethane in hexane. The sam-
ple extract was then loaded onto a Strata1 NH2 cartridge (200 mg/3 mL,
Phenomenex, Torrance, CA), preconditioned with 5 mL of 80% metha-
nol in acetone and 5 mL of hexane. The cartridge was washed with 5
mL of hexane and eluted with 5 mL of 80% methanol in acetone. The
eluate was concentrated to 0.5 mL under a gentle stream of nitrogen
resulting in the free BPA fraction.
To determine conjugated BPA, 1 mL of Milli-Q H2O and 1 mL of 2
lL/mL b-glucuronidase (from Helix pomatia, 145,700 units/mL, Sigma,
St Louis, MO) were added to the residue from free-BPA aliquot. 13C12-
BPA was added and digested at 378C for 12 hr. The sample was
extracted thrice with ethyl acetate (5 1 3.5 1 3.5 mL) and purified by
passing through Strata1 NH2 cartridge as described above. The final elu-
ate was concentrated to 0.5 mL. A high-performance liquid chromato-
graph (HPLC) interfaced with API 2000 electrospray triple-quadruple
mass spectrometry (ESI-MS/MS; Applied Biosystems, Foster City, CA)
was used for the quantification of free and conjugated BPA [Padma-
nabhan et al., 2008]. Ten microliters of the extract was injected onto an
analytical column (Betasil1 C18, 100 3 2.1 mm column; Thermo Elec-
tron Corporation, Waltham, MA), which was connected to a Javelin1
guard column (Betasil1 C18, 20 3 2.1 mm). The mobile phase flow
rate was 300 lL/min. The mobile phase consisting of methanol and
water started at a gradient of 25% methanol to 99% methanol in 4 min
and was held for 10 min before reverting to its initial condition. The
MS/MS was operated in the electrospray negative ionization mode and
optimized to transmit the [M-H]- ion before fragmentation of one or
more product ions. Cone voltage and collision energies were 30 and 25
V, respectively. The capillary voltage was 4.5 KV, and desolvation tem-
perature was 4008C. Multiple reaction monitoring transitions monitored
were 227 > 212 for BPA, and 239 > 224 for 13C12-BPA.
A procedural blank was analyzed with every 10 samples to check for
interferences or laboratory contamination. The limit of quantitation
(LOQ) of BPA was 0.1 ng/g. The LOQ was calculated as twice the con-
centration of the "lowest acceptable calibration standard"; the amount of
sample taken for analysis and final extract volume. The mean recovery
of 13C12-BPA spiked into samples was 96%. Reported concentrations
were corrected for the recoveries of the internal standard (isotope dilu-
tion method). BPA standards spiked into selected sample matrices and
passed through the entire analytical procedure yielded a mean recovery
of 101%. An external calibration curve was prepared by injecting 10 lL
of 0.05, 0.1, 0.2, 0.5, 1, 2, 5, 10, 50, and 100 ng/mL standards and the
calibration coefficient was 0.99.
In order to compare mouse liver BPA concentrations to physiologically
relevant levels in humans, free and conjugated BPA were measured in 51
human fetal liver samples obtained from the NIH-funded (R24 HD000836-
47) Birth Defects Research Laboratory fetal tissue bank at the University
of Washington, Seattle. These tissues were derived from conceptuses with
gestational ages ranging from 74 to 120 days. Information provided with
these tissues include gestational age and sex; occasionally race is indicated.
The health status of the individuals is unknown but presumed to have been
healthy and with no known chromosomal abnormalities. Prior to shipment
to the University of Michigan, samples were flash frozen with liquid nitro-
gen and stored in polycarbonate-free tubing. Fetal liver tissues were proc-
essed for BPA levels as described above.
To ensure no contamination was introduced into the sample prepara-
tion process, a negative control of BPA-free water was processed identi-
cally as the mouse and human samples described above and resulted in
free and conjugated BPA levels below the LOQ. For calculation of mean
and median BPA concentrations, liver BPA levels below the LOQ were
assigned a value of 0.071, which was estimated by dividing the LOQ
(0.1 ng/g) by the square root of 2.
RESULTS
Gestational BPA exposure at 50 ng BPA/kg (n 5 14 lit-
ters, 107 total offspring), 50 lg BPA/kg (n 5 9 litters, 67
total offspring), or 50 mg BPA/kg (n 5 13 litters, 91 total
offspring) diet did not significantly influence litter size (P
5 0.84), survival (P 5 0.86), genotypic ratio (P 5 0.49),
or sex ratio (P 5 0.16) in comparison to control offspring
(n 5 11 litters, 86 total offspring; Table II). BPA exposure
was, however, significantly associated with lower wean
weight of ng exposed a/a and Avy/a offspring (mean weight
8.65 g in ng versus 9.28 g in control; P 5 0.03) but not lg
or mg exposed offspring (Table II). When d22 body weight
analysis is restricted to a/a animals only, the decreased
body weight in ng exposed offspring, and not in lg and mg
exposed offspring, is still observed (mean weight 8.24 g in
ng versus 9.15 g in control; P 5 0.01).
Global DNAMethylation
Global CCGG DNA methylation levels throughout the
mouse genome were measured in Avy/a and a/a offspring
d22 tail DNA using the LUMA assay (Table III). Mean
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TABLE I. PCR Primers and Sequences: Primers (50 to 30) and sequences to analyze for DNA methylation quantification via
pyrosequencing for candidate genes
Primer/sequence
to analyze Avy Assay CabpIAPAssay
Forward PCR primer ATTTTTAGGAAAAGAGAGTAAGAAGTAAG ATTATTTTTTGATTGGTTGTAGTTTATGG
Reverse PCR primer CTACAAAAACTCAAAAACTCA CACCAACATACAATTAACA
Sequencing primer TAGAATATAGGATGTTAG TAGAATATAGGATGTTAG
Sequence to analyze C/TGTTATTTTGTGAC/TGGC/TGAATGTGGGGGC/TGGTT C/TGTTATTTTGTGAC/TGGC/TGAATGTGGGGGC/TGGTT
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methylation did not differ by sex (P 5 0.58), genotype (P
5 0.43), or coat color (P 5 0.93). Offspring exposed to
the 50 mg BPA/kg diet demonstrated an average of
59.3% global DNA methylation in comparison to control
offspring with measured percent global methylation of
51.6 (n 5 71 and 60, respectively; P 5 0.01). Offspring
exposed to the 50 lg BPA/kg diet also exhibited signifi-
cantly higher average percent global DNA methylation of
60.3 compared with controls (n 5 52 and 60, respec-
tively; P 5 0.008). Lastly, the offspring exposed to a 50
ng BPA/kg diet showed significantly higher average per-
cent global methylation of 58.8 compared with controls (n
5 74 and 60, respectively; P 5 0.02). There were no stat-
istically significant differences in global methylation
among the three BPA exposed groups (data not shown).
Maternal Dietary Exposure Coat Color Shift
The total number of offspring evaluated for coat color
shift was among 11 litters from the corn oil control group
(n 5 39 Avy/a offspring), 13 litters from the mg BPA/kg
supplemented group (n 5 45 Avy/a offspring), 9 litters from
the lg BPA/kg supplemented group (n 5 32 Avy/a off-
spring), and 14 litters from the ng BPA/kg supplemented
group (n 5 48 Avy/a offspring). Perinatal BPA exposure
through maternal diet shifted the coat color distribution of
Avy/a offspring in a dose-dependent fashion. Maternal die-
tary exposure to 50 mg BPA/kg shifted the coat color distri-
bution of genetically identical d22 Avy/a offspring toward
yellow in comparison to control offspring (P 5 0.006; Fig.
2A). Twenty-nine percent of the 50 mg BPA/kg exposed
offspring were classified as yellow coat color compared
with only 15% of control offspring. Conversely, maternal
dietary exposure to 50 lg BPA/kg resulted in a statistically
significant altered coat color distribution in comparison to
controls (P 5 0.04; Fig. 2B). Twenty-five percent of the 50
lg BPA/kg exposed offspring were classified as pseudoa-
gouti compared with only 12% of the control offspring;
however, the 50 lg BPA/kg exposed offspring were also
more likely to be classified as slightly mottled (31% com-
pared with 18%). Finally, maternal dietary exposure to 50
ng BPA/kg resulted in increased incidence of slightly mot-
tled and heavily mottled offspring compared with controls
(P 5 0.02) but did not shift the coat color distribution to-
ward the pseudoagouti or yellow phenotype (Fig. 2C).
Candidate Gene DNAMethylation at Avy and CabpIAP
Site-specific and average DNA methylation in d22 tail
tissue at four CpG sites (sites 6–9) in the cryptic promoter
of the Avy IAP was quantified using bisulfite pyrosequenc-
ing on Avy/a offspring (Fig. 1A). The mg exposure group
(n 5 43 Avy/a offspring) demonstrated an average methyl-
ation of 24.3% across the four CpG sites in comparison
to 35.6% average methylation of the controls (Table IV; n
5 38 Avy/a offspring; P 5 0.03). Evaluation of each indi-
vidual CpG site indicated a significant decrease in methyl-
ation at sites 6 (P 5 0.03), 7 (P 5 0.02), and 8 (P 5
0.02) in the mg exposed offspring versus control. Methyl-
ation at site 9 was marginally significantly lower (P 5
0.07). Average methylation across the four CpG sites of
the lg (n 5 32 Avy/a offspring; P 5 0.97) and ng (n 5
48 Avy/a offspring; P 5 0.79) exposed offspring did not
differ in comparison to the control group (Table IV).
There were no significant differences in methylation at
sites 6–9 of lg (P 5 0.96, 0.93, 0.99, and 0.80, respec-
tively) and ng (P 5 0.79, 0.60, 0.75, and 0.99, respec-
tively) groups in comparison to the control group.
DNA methylation in d22 tail tissue at four CpG sites
(sites 6–9) in the CabpIAP metastable epiallele [Druker
et al., 2004) was measured in both Avy/a and a/a offspring
(Fig. 1B). In comparison to the control group (n 5 82
Avy/a and a/a offspring), the mg exposed offspring (n 5
85 Avy/a and a/a offspring) showed no difference in aver-
age methylation across the four CpG sites (83.1 and
83.6%, respectively; P 5 0.64; Table IV). Average meth-
ylation across the four CpG sites in the lg exposed off-
spring (n 5 67 Avy/a and a/a offspring), however, was
increased compared with controls (85.8 and 83.1%,
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TABLE II. Litter Parameters: Offspring litter size, survival rate, wean weight, genotypic ratio, and sex ratio across exposure
groups
Exposure N (litter)
Mean no.
pups
Pup survival
rate
Mean wean
weight (g)
Mean percent
a/a offspring
Mean percent
male offspring
Control 11 7.82 0.95 9.28 55 45
mg 13 7.00 0.95 9.27 51 51
lg 9 7.44 0.91 9.33 52 54
ng 14 7.64 0.93 8.65* 55 57
*indicates a P < 0.05 compared with control exposure group.
TABLE III. Global DNA Methylation: LUMA methylation
levels in tail DNA among Avy/a and a/a offspring
Exposure N
Mean percent
methylation (SD)
P-value
(compared with control)
Control 60 51.6 (17.9)
mg 71 59.3 (15.2) 0.02
lg 52 60.3 (13.4) 0.007
ng 74 58.8 (9.8) 0.01
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respectively; P 5 0.02). Site-specific methylation showed
increased methylation at sites 6, 8, and 9 in the lg
exposed group versus the controls (P 5 0.01, 0.02, and
0.04, respectively). The ng exposure group (n 5 107 Avy/
a and a/a offspring) displayed an average methylation
across the four CpG sites of 84.3% compared with 83.1%
in the control group (P 5 0.25). Sites 8 and 9 exhibited
statistically significant increased methylation in ng
exposed offspring when compared with controls (P 5
0.02 and 0.04, respectively).
Liver BPA Measurements
Free and conjugated BPA concentrations were analyzed
in a subset of d22 mouse liver samples (1 pup per litter)
from each BPA exposure and control group as well as in
51 human fetal liver samples (Table V). Total BPA (free
plus glucuronide-conjugated) concentrations measured in
the 50 mg BPA/kg exposed mice ranged from 9.46 to 870
ng/g (mean 5 441; median 5 472; n 5 9). Total BPA in
animals exposed to 50 lg BPA/kg ranged from below
LOQ to 11.3 ng/g (mean 5 2.02; median 5 0.56; n 5
10). BPA concentrations in the liver from mice exposed
to 50 ng BPA/kg ranged from below LOQ to 13.0 ng/g
(mean 5 2.78; median 5 0.31; n 5 11). Total BPA in
the control group ranged from below LOQ to 11.5 ng/g
(mean 5 4.26; median 5 4.24; n 5 10). To compare
mouse liver BPA concentrations to physiologically rele-
vant doses in humans, fetal human liver tissues were also
analyzed for free and glucuronide-conjugated BPA. Total
BPA concentrations in human fetal liver ranged from
below LOQ to 96.8 ng/g (mean 5 10.8, median 5 3.39;
n 5 51). The overlap between mouse liver BPA levels
and human fetal liver BPA levels indicates that the exper-
imental approach used for dietary animal exposure cap-
tures a relevant and full range of human BPA exposure.
DISCUSSION
In the current study, we report dose-dependent pheno-
typic and epigenetic responses following maternal dietary
exposure to three levels of BPA. First, we observed a
decrease in d22 wean body weight in a/a and Avy/a off-
spring exposed to 50 ng/kg diet of BPA versus control
offspring. This association persists when analysis is re-
stricted to a/a offspring alone, indicating that this effect is
not associated with the epigenetically controlled adult
onset obesity associated with Avy/a offspring, but rather
manifests as a result of perinatal BPA exposure. Both
low-birth weight in humans and early BPA exposure in
animal models have been correlated to adult onset obesity
[Barker, 2004; Heindel et al., 2009]; hence, it will be of
interest to further evaluate early BPA exposure as a
potential obesogen in adulthood. Body weight differences
were not detected in offspring exposed to either 50 lg or
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Fig. 2. Coat color distribution (A) Coat color phenotype distribution
among 50 mg/kg BPA exposed offspring (n 5 45) versus corn oil con-
trol offspring (n 5 38). 50 mg/kg BPA maternal intake demonstrates a
shift in offspring coat color toward yellow (P 5 0.006). (B) Coat color
phenotype distribution among 50 l*g/kg BPA offspring (n 5 32) and
versus corn oil control offspring. 50 l*g/kg BPA maternal intake demon-
strates a shift in coat color toward pseudoagouti (P 5 0.04). (C) Coat
color phenotype distribution among 50 ng/kg BPA offspring (n 5 48)
versus corn oil control offspring. 50 ng/kg BPA maternal intake demon-
strates a shift in offspring coat color toward heavily mottled/pseudoa-
gouti (P 5 0.02). [Color figure can be viewed in the online issue, which
is available at wileyonlinelibrary.com.]
Epigenetic Responses FollowingMaternal Exposure to Bisphenol A 339
50 mg BPA/kg diet indicating a nonmonotonic dose
response of wean weight and, corroborating previous stud-
ies using multiple doses of BPA with nonlinear outcomes
[Rubin et al., 2001; Honma et al., 2002]. Mechanisms of
action supporting nonmonotonic effects BPA, and endo-
crine disruptors in general, should be further investigated.
Global methylation of the mouse genome assessed
using the LUMA assay reveals a significant increase in
methylation across all BPA exposure groups in compari-
son to controls. This assay provides a measure of methyl-
ation at CCGG sites throughout the entire genome regard-
less of location, representing the degree to which the ge-
nome is globally methylated. The LUMA assay has been
extensively used in analysis of human cancers [Lee et al.,
2008; Deneberg et al., 2010; Poage et al., 2011]. There
are limited studies, however, exploring environmental
and/or nutritional exposures and their impact on global
methylation [Gallou-Kabani et al., 2010]. Recently, using
a mouse model, Gallou-Kabani et al. [2010] associated
maternal high fat diet with decreased placental tissue
DNA methylation in female offspring. The global
decrease in CCGG methylation was not associated with
decreased methylation at LINE-1 or B1 repetitive ele-
ments. Gene specific methylation at the Igf2r gene in
female offspring exposed to high fat diet, on the other
hand, was increased. Thus, it is important to note that the
LUMA assay is restricted to methylation of CCGG
sequences throughout the genome and is not necessarily
representative of environmentally induced local changes
at candidate genes or repetitive content derived from
transposable elements such as LINE-1 and B1.
We also note dose-dependent shifts in the coat color
distribution of genetically identical Avy/a offspring
exposed to a 50 mg, lg, or ng/kg diet of BPA perinatally.
The coat color distribution of offspring exposed to a 50
mg/kg diet of BPA displays a shift toward the yellow
obese phenotype, reproducing our 2007 single dose study
results [Dolinoy et al., 2007], whereas the lg dose off-
spring displays a shift toward the pseudoagouti lean coat
color phenotype. Average methylation at the Avy locus of
the mg exposed offspring is significantly decreased in
comparison to the control group, providing epigenetic val-
idation of the coat color distribution shift. In contrast, av-
erage methylation at the Avy locus of the lg exposure
group was not statistically significant. An excess of cate-
gorization as slightly mottled Avy/a offspring may have
offset a hypermethylation response among the lg expo-
sure group when compared with the control group.
Increased methylation in lg offspring compared with con-
trol offspring was, however, detected at the CabpIAP met-
astable epiallele, signifying that perinatal exposure to
BPA at this dose increases methylation at this particular
epigenetically labile locus. Taken together, these results
(1) indicate that methylation at more than one locus is
variable after perinatal exposure to BPA, (2) strengthen
the evidence for nonmonotonic dose-dependent effects of
BPA, and (3) provide evidence that variable dose levels
of BPA act across different biological pathways [Vanden-
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TABLE IV. Percent Methylation Summary
Locus N Exposure
Mean percent methylation
(SD) across CpG sites 6–9
Mean percent
methylation
(SD) site 6
Mean percent
methylation
(SD) site 7
Mean percent
methylation
(SD) site 8
Mean percent
methylation
(SD) site 9
Avy (Avy/a offspring) 38 Control 35.6 (26.4) 34.5 (26.4) 35.2 (23.2) 35.5 (27.2) 37.3 (30.3)
43 mg 24.3 (18.7)** 23.7 (18.9)** 24.1 (16.5)** 22.6 (18.8)** 26.7 (21.6)*
32 lg 35.9 (27.5) 34.2 (27.8) 34.7 (23.7) 35.4 (27.7) 39.2 (31.5)
48 ng 34.1 (25.2) 33.1 (25.5) 32.6 (21.9) 33.7 (25.4) 37.2 (28.8)
CabpIAP (Avy/a and
a/a offspring)
82 Control 83.1 (8.2) 84.6 (8.1) 81.5 (8.4) 78.5 (9.7) 88.0 (9.3)
85 mg 83.6 (6.4) 85.8 (6.4) 81.4 (6.9) 79.1 (7.1) 88.3 (7.7)
67 lg 85.8 (5.6)** 87.5 (5.4)** 83.3 (6.6) 81.8 (6.5)** 90.6 (6.2)**
107 ng 84.3 (6.0) 86.0 (5.8) 82.3 (7.2) 79.3 (7.6)** 89.6 (6.1)**
*indicates P < 0.10 compared with control exposure group.
**indicates P < 0.05 compared with control group. Methylation status of Avy and CabpIAp loci from tail DNA.
TABLE V. BPA Liver Concentrations (ng/g): Measurements from mouse d22 Avy/a offspring tissue liver and human fetal liver
tissue ranging from gestational ages 74–120
Mice fed mg/kg
diet (n 5 9)
Mice fed lg/kg
diet (n 5 10)
Mice fed ng/kg
diet (n 5 11)
Mice fed control
diet (n 5 10)
Human
fetal (n 5 51)
Range Total BPA (ng/g) 9.5–870 <LOQ-11.3 <LOQ-13 <LOQ-11.5 <LOQ-96.8
Mean (SD) free-BPA (ng/g) 164 (132) 1.8 (3.5) 1.8 (2.9) 3.7 (2.8) 7.6 (12.2)
Mean (SD) conjugated-BPA (ng/g) 278 (233) 0.3 (0.3) 1.0 (1.6) 0.6 (0.8) 3.2 (8.0)
Mean (SD) total BPA (ng/g) 441 (338) 2.0 (3.5) 2.8 (4.5) 4.3 (3.5) 10.8 (18.5)
Median Total BPA (ng/g) 472 0.6 0.3 4.2 3.4
**LOQ 5 Limit of quantitation (0.1 ng/g).
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berg et al., 2009]. Genome-wide methylation and tran-
scriptomics investigation should now be considered in
light of this evidence.
Because of BPA’s ubiquitous existence in the environ-
ment and the ongoing debate about whether human internal
BPA levels pose a health concern [Volkel et al., 2002; Gins-
berg et al., 2009], it is of significance that animal studies
capture human physiologically relevant exposure levels to
determine BPA’s impact on human health outcomes. In the
present study, we aimed to achieve physiologically relevant
levels by including a high (mg), medium (lg), and low (ng)
dose of BPA in the maternal diet. Calafat et al. [2008]
reported a range of urinary total BPA (free and conjugated)
of 0.4–149 ng/mL representative of individuals 6 years of
age or older (n 5 2,517) in subjects measured as a part of
the 2003–2004 National Health and Nutrition Examination
Survey (NHANES). Lang et al. [2008] reported urinary total
BPA levels ranging from 3.34 to 4.48 ng/mL in individuals
aged 18 years or older who have normal BMI (n 5 469)
from the 2003–2004 NHANES. Additionally, Padmanabhan
et al. [2008] measured a range of 0.5–22.3 ng/mL of circu-
lating free BPA (unconjugated) in maternal blood collected
upon delivery.
We report d22 mouse liver BPA measurements ranging
from below the limit of quantitation (LOQ) to 870 ng/g
across all exposure groups comparable to human fetal
liver measurements ranging from below LOQ to 96.8 ng/
g. Ideally, liver BPA levels would be measured in fetal
mouse tissues and compared with developmentally
matched human fetal tissues; however, study design and
current analytical requirements preclude this direct com-
parison. Nonetheless, mouse liver total and free BPA lev-
els among Avy/a offspring exposed to 50 mg BPA/kg diet
in our study range from 9.46 to 870 and 2.68 to 390 ng/g,
respectively, (Table V) and are comparable to mouse cir-
culating serum BPA concentrations recently reported in
adult mice exposed to 100 mg BPA-d6/kg diet ad libitum
for a 24-hr period [Sieli et al., 2011]. Sieli et al. [2011]
show that in comparison to mice receiving a single oral
bolus exposure of 20 mg BPA/kg body weight, animals
fed BPA in the diet reach a maximum serum concentra-
tion of total and unconjugated (free) BPA at 6 hr of 802
and 18.8 ng/mL, respectively compared with 1 hr in the
bolus group. Moreover, the observed serum concentrations
following BPA administration in the diet are within the
range of human exposure. Within the current study, we
also observe a high degree of interindividual variation in
mouse liver BPA concentrations within a particular dose
group as well as the controls, perhaps reflecting time and
metabolism effects associated with recent feeding bouts
and/or continued nursing of pups. Unlike single bolus
ingestion or injection routes of exposure, dietary exposure
through feed results in inherent interindividual variability.
It is important to note that we do not see a profound dif-
ference in mean or median mouse liver BPA concentra-
tions among control and the two low dose groups; in fact,
BPA is detected in some control animals despite housing
in BPA-free caging and receiving BPA-free water. A limi-
tation of this study is possible BPA cross-contamination
via air given that animals were housed in a single room
to minimize environmental heterogeneity that contributes
to underlying epigenetic lability.
To our knowledge, this is the first study conducted using
the viable yellow agouti epigenetic biosensor to analyze off-
spring phenotypic and epigenetic effects following multiple
dose levels of either an environmental exposure or nutri-
tional agent. Isogenic Avy mice allow for reproducible
experiments as seen here with the coat color shift toward
yellow in the Avy/a offspring exposed to the 50 mg BPA/kg
diet [Dolinoy et al., 2007]. We also took a candidate gene
approach limited to metastable epialleles unique to murine
models and a global CCGG sequence assay. In order to con-
duct an unbiased epigenetic analysis, genome-wide methyla-
tion experiments must be applied in animal models. Epige-
nome-wide approaches will generate a template useful for
the foundation and understanding of the full effect of BPA
on the mouse epigenome. Concurrent studies are needed to
assess BPA’s effect on the human epigenome, and whether
labile loci between the mouse and human display significant
overlap. In understanding the epigenome as a whole, one
must also consider other epigenetic mechanisms such as his-
tone modifications and microRNA interference separately
and in conjunction with each other, and their sensitivity to
environmental disruptions. Recently, DNA methylation and
histone modifications have been observed to act in concert
with one another at the Avy metastable epiallele [Dolinoy
et al., 2010]. Increasing studies focusing on multiple epige-
netic mechanisms will strengthen the understanding of envi-
ronmentally induced alterations to the epigenome.
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